Cephalon Sues Barr Again Over Generic Fentora ANDA
The complaint, lodged Wednesday in the U.S. District Court for the District of Delaware, claims an Abbreviated New Drug Application Barr submitted to regulators constitutes infringement of two patents covering Fentora.
Barr’s decision to file the ANDA constitutes an infringement of U.S. Patent Numbers 6,200,604 and 6,974,590, titled...
Already a subscriber? Click here to login